Molecular tumor board
Complex cancer requires integrated thinking.
A molecular tumor board is a structured discussion in which several kinds of information are considered together, rather than one report being read on its own.
How it works
Six inputs, one discussion.
- Clinical data
- Pathology
- Imaging
- Genomics
- Biomarkers
- Previous treatment
- Molecular Tumor Board
- Clinical interpretation
- Treatment discussion
Why it helps
Interpretation is the difficult part.
Genomic reports frequently contain findings of uncertain significance, conflicting evidence or alterations without an established treatment implication. A board setting is where those ambiguities are addressed honestly.
- Complex or conflicting molecular findings
- Rare tumours and cancers of unknown primary
- Disease progressing on standard treatment
A board discussion produces an interpretation and a set of options to discuss. It does not guarantee that a new treatment avenue exists. Second opinion
Where a complex case raises the question of an advanced therapy pathway — for example cellular therapy in a relapsed hematologic malignancy — the board setting is where that question is examined alongside standard options. Eligibility itself is decided through specialist assessment, not in the discussion alone. CAR-T cell therapy
Submit a case for review.
Referring clinicians and patients can share pathology, imaging and molecular reports for structured review.